Request Legal Help Now - Free

Following Suit: Risperdal Lawsuit Update

. By

Risperdal (generic name Risperidone) is an atypical antipsychotic that works by changing the activity of certain natural substances in the brain. Developed by Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson (J&J), Risperdal was approved by the Food and Drug Administration (FDA) in 1993 for the treatment of schizophrenia in adults. Risperdal side effects include Risperdal gynecomastia (male breast growth), tardive dyskinesia, high blood sugar and diabetes, stroke, heart attack, and even death.

• The antipsychotic drug has also been linked to an increased risk of young males developing gynecomastia, an increase in breast tissue.

• Lawsuits are being filed against J&J alleging the company failed to warn physicians and patients about the increased risk of gynecomastia, especially in young, developing boys. Some of the victims have undergone mastectomies because of the size of their breasts, and suffered considerable psychological trauma.

• Although Risperdal carries a warning about the risk, some doctors have called on the FDA to strengthen the warning.

• Boys who have developed gynecomastia may experience pain or nipple discharge. Mild cases can be resolved with liposuction, while more severe cases will require a mastectomy.

• According to reports, two boys had mastectomies to decrease their breast tissue after taking Risperdal (see Risperdal Gynecomastia Lawsuits and Settlements below).

• As of September 2012, more than 420 Risperdal lawsuits had been filed, 130 of which are Rispedal gynecomastia claims.

Risperdal Gynecomastia Lawsuits and Settlements

• Currently, over 130 Risperdal lawsuits are pending against J&J and Janssen alleging that the boys and men who took the drug developed breasts.

• Aaron Banks filed a Risperdal gynecomastia lawsuit alleging that he was treated with Risperdal at the ages of nine and 14. He subsequently developed gynecomastia, which led to prolonged psychological trauma. In September 2013, J&J settled with Banks the day the trial was meant to begin, for an undisclosed amount. Banks was 21 years old at the time.

J&J’s Illegal Off-Label Marketing

• In November 2013, J&J agreed to pay $2.2 billion to settle charges with the US Department of Justice (DOJ) over the alleged illegal marketing of Risperdal, Invega and Natrecor, including promotion for uses not approved as safe and effective by the FDA, and payment of kickbacks to physicians and to the nation’s largest long-term care pharmacy provider.

• The global resolution is one of the largest health care fraud settlements in U.S. history, including criminal fines and forfeiture totaling $485 million, and civil settlements with the federal government and states totaling $1.72 billion.


Risperdal Legal Help

If you or a loved one have suffered losses in this case, please click the link below and your complaint will be sent to a drugs & medical lawyer who may evaluate your Risperdal claim at no cost or obligation.


Posted by

is there a links between autisum and respidal ?

Posted by

i am currentyly taking risperdal prescribed to me


Fields marked * are mandatory. Please read our comment guidelines before posting.


Note: Your name will be published with your comment.

*Email Address:

Your email will only be used if a response is needed.
*Your Comment:

Are you the defendant or a subject matter expert on this topic with an opposing viewpoint? We'd love to hear your comments here as well, or if you'd like to contact us for an interview please submit your details here.

Click to learn more about
Request Legal Help Now! - Free